BEAM
BEAM clinical trials: Beam Therapeutics Inc.
Every trial on ClinicalTrials.gov where Beam Therapeutics Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 11
- Trials linked
- 9
- As lead sponsor
- 2
- As collaborator
- 2
- Primary completions as lead sponsor, next 90 days
BEAM on the catalyst calendar · BEAM registry changes
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT07910422Intradiscal Ozone/Oxygen Injection for Treatment of Contained Lumbar Disc HerniationBeam Research, Inc. · Lumbar Disc HerniationEnrolling by invitationBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2028Sponsor estimatePhase 1/Phase 2NCT06389877A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)Beam Therapeutics Inc. · Alpha 1-Antitrypsin DeficiencyRecruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 12, 2043Sponsor estimateNo phase registeredNCT07373639A Long-term Follow-up Study in Patients Who Received BEAM-101Beam Therapeutics Inc. · HemoglobinopathyRecruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2028Sponsor estimatePhase 1/Phase 2NCT05456880BEACON: A Study Evaluating the Safety and Efficacy of BEAM-101 in Patients With Severe Sickle Cell DiseaseBeam Therapeutics Inc. · Sickle Cell DiseaseActive, not recruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 29, 2026Sponsor estimatePhase 1NCT07304791This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics...Beam Therapeutics Inc. · Healthy SubjectsRecruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 30, 2027Sponsor estimatePhase 1/Phase 2NCT06735755A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia...Beam Therapeutics Inc. · Glycogen Storage Disease Type IaRecruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 17, 2024ActualNo phase registeredNCT07183735A Crossover Trial to Examine the Efficacy of a Powder to Improve Sleep Quality and PerformanceBeam · SleepCompletedBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1/Phase 2NCT05885464A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell...Beam Therapeutics Inc. · Lymphoblastic LymphomaActive, not recruitingBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 30, 2022ActualNo phase registeredNCT05521243An Exploratory Investigation of a Supplement to Enhance Sleep Quality and QuantityBeam · SleepCompletedBEAMLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2029Sponsor estimatePhase 1NCT06934382Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or LymphomaStephan Grupp MD PhD · T-Cell Acute Lymphoblastic Leukemia/LymphomaActive, not recruitingBEAMCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimateNo phase registeredNCT06071377Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)National Alliance for Sickle Cell Centers · Sickle Cell TraitRecruitingBEAMCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 11 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner